| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |